Engaged in diverse basic, translational and clinical research, our faculty routinely publish in prestigious journals and successfully compete for major grants from national funders.
A phase 3 double-blind study to evaluate the efficacy and safety of oral ozanimod compared to oral fingolimod in children and adolescents with relapsing-remitting multiple sclerosis. Michael Dwyer, III (Co-Investigator). Bristol Myers Squibb. $1,649,376. 6/1/2023-12/1/2032.
CTSA State University of New York at Buffalo. Zackary Falls (Contributor). National Center for Advancing Translational Sciences (NCATS). $29,204,726. 1/1/2025-12/1/2031.
Clinical and Translational Science Award. Core Operations Special Populations. Ralph Benedict (Co-Investigator). NIH. $29,204,726. 1/1/2025-12/1/2031.
Clinical and Translational Science Award. University at Buffalo Clinical and Translational Science Institute. Timothy Murphy (Principal Investigator). NIH. 1/1/2025-12/1/2031.
Selective galactosylceramidase ablation to study the pathogenesis of Krabbe leukodystrophy. Pablo Paez (Co-Investigator). National Institute of Neurological Disorders and Stroke (NINDS). $1,950,000. 2/1/2025-1/1/2030.
Selective galactosylceramidase ablation to study the pathogenesis of Krabbe leukodystrophy. Daesung Shin (Principal Investigator). NIH. $2,013,407. 12/1/2024-12/1/2029.
Overdose Data to Action in States (OD2A): Bio surveillance. Brian Clemency (Principal Investigator). Centers for Disease Control and Prevention (Subaward from NYS Department of Health/Health Research Inc.). $250,000. 9/1/2024-8/1/2029.
Rhythm Evaluation for AntiCoagulaTion for Atrial Fibrillation (REACT AF). Anne Curtis (Co-Investigator). NIH. $66,278. 8/1/2023-7/1/2029.
Leveraging small molecule inhibitors to improve CD19 CAR T cell immunotherapy for KMT2A-rearranged ALL. Lisa Niswander (Principal Investigator). NIH/NCI. 7/1/2024-7/1/2029.
Characterizing the role of Elevated dNTP pools in sensitizing the replisome. Jennifer Surtees (Principal Investigator). NIGMS. $2,448,745. 9/1/2024-6/1/2029.
NIMHD Center of Excellence in Investigator Development and Community Engagement. Timothy Murphy (Principal Investigator). NIH. $3,600,000. 7/1/2024-6/1/2029.
Molecular Mechanisms of Severe Diabetic Retinopathy. Joshua Jianxin Wang (Co-Investigator). NIH/NEI. $2,374,855. 2/1/2020-5/1/2029.